The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $0.82 in the prior trading day, Outset Medical Inc (NASDAQ: OM) closed at $0.79, down -3.45%. In other words, the price has decreased by -$3.45 from its previous closing price. On the day, 0.99 million shares were traded. OM stock price reached its highest trading level at $0.8249 during the session, while it also had its lowest trading level at $0.78.
Ratios:
Our goal is to gain a better understanding of OM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.04 and its Current Ratio is at 6.49. In the meantime, Its Debt-to-Equity ratio is 4.23 whereas as Long-Term Debt/Eq ratio is at 4.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 13 ’25 when Trigg Leslie sold 33,227 shares for $0.81 per share. The transaction valued at 26,914 led to the insider holds 861,397 shares of the business.
Nash Marc sold 15,011 shares of OM for $12,159 on Jan 13 ’25. The SVP Operations and R&D now owns 222,291 shares after completing the transaction at $0.81 per share. On Jan 13 ’25, another insider, Brottem John L., who serves as the General Counsel of the company, sold 20,492 shares for $0.81 each. As a result, the insider received 16,599 and left with 205,028 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 41825604 and an Enterprise Value of 67959200. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at 0.592 whereas that against EBITDA is -0.552.
Stock Price History:
The Beta on a monthly basis for OM is 2.05, which has changed by -0.79586565 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, OM has reached a high of $5.22, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is -19.98%, while the 200-Day Moving Average is calculated to be -59.76%.
Shares Statistics:
The stock has traded on average 1.07M shares per day over the past 3-months and 2583440 shares per day over the last 10 days, according to various share statistics. A total of 52.54M shares are outstanding, with a floating share count of 48.77M. Insiders hold about 7.88% of the company’s shares, while institutions hold 98.30% stake in the company. Shares short for OM as of 1735603200 were 2463795 with a Short Ratio of 2.29, compared to 1732838400 on 2795417. Therefore, it implies a Short% of Shares Outstanding of 2463795 and a Short% of Float of 5.48.
